Investor Relations

alt
CAH 65.62 -0.39 -0.59% Volume: 1,208,593 08/17/17 13:06

Investor Relations

alt

Financial Highlights

Non-GAAP diluted EPS from continuing operations1

$5.24

13.4% Five-year CAGR1,2

Financial Highlights

Non-GAAP Operating Earnings1 (in millions)

$2,895

12.0% Five-year CAGR1,2

Financial Highlights

Dividends per share

$1.55

14.7% Five-year CAGR2

1Click here for a reconciliation of the differences between the non-GAAP and GAAP financial measures.
2Reflects growth between FY12 and FY16, using FY11 as a base.

News Highlights

July 6, 2015

DUBLIN, Ohio, July 6, 2015 /PRNewswire/ -- Cardinal Health today announced the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners.

Read more

October 4, 2015

DUBLIN, Ohio, Oct. 4, 2015 /PRNewswire/ -- Cardinal Health today announced that it has completed the acquisition of Johnson & Johnson's Cordis business, a global leader in cardiology and endovascular devices, for $1.944 billion.

Read more

November 19, 2015

Read more